| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Tegexibaiyin Wang, Fen Liu, Xiujuan Jia, Jing Tan, Baopeng Qi, Jingxue Guo, Qiri Mu, Hong Zhan. Serum Level of Brain-Derived Neurotrophic Factor (BDNF) Associated with Depression in Patients with Rosacea: A Candidate Predictive Biomarker. Clinical, cosmetic and investigational dermatology. vol 15. 2022-06-09. PMID:35677222. |
serum level of brain-derived neurotrophic factor (bdnf) associated with depression in patients with rosacea: a candidate predictive biomarker. |
2022-06-09 |
2023-08-14 |
Not clear |
| Chunhui Zhang, Xuefang Wang, Qinghua Zhu, Yongxia Mei, Zhenxiang Zhang, Hui X. Decreased Serum Brain-Derived Neurotrophic Factor in Poststroke Depression: A Systematic Review and Meta-Analysis. Frontiers in psychiatry. vol 13. 2022-06-06. PMID:35664480. |
there were conflicting results on the comparison of brain-derived neurotrophic factor (bdnf) levels between poststroke depression (psd) patients and stroke patients without psd among previous studies. |
2022-06-06 |
2023-08-14 |
Not clear |
| Yan-Mei Chen, Hua Fan, Jie Huang, Tian-Shun Shi, Wei-Yu Li, Cheng-Niu Wang, Bo Jiang, Jian-Feng Li. Hippocampal F3/Contactin plays a role in chronic stress-induced depressive-like effects and the antidepressant actions of vortioxetine in mice. Biochemical pharmacology. 2022-05-24. PMID:35609645. |
currently, it has been demonstrated that besides monoaminergic dysfunction, depression is accompanied by several other important pathological phenomena such as impaired neurogenesis and decreased brain-derived neurotrophic factor (bdnf)-camp response element binding protein (creb) signaling cascade in the hippocampus. |
2022-05-24 |
2023-08-13 |
mouse |
| Rintaro Fujii, Keita Watanabe, Naomichi Okamoto, Tomoya Natsuyama, Hirofumi Tesen, Ryohei Igata, Yuki Konishi, Atsuko Ikenouchi, Shingo Kakeda, Reiji Yoshimur. Hippocampal Volume and Plasma Brain-Derived Neurotrophic Factor Levels in Patients With Depression and Healthy Controls. Frontiers in molecular neuroscience. vol 15. 2022-05-23. PMID:35600081. |
the aim of the present study was to investigate associations between hippocampal subfield volumes and plasma levels of brain-derived neurotrophic factor (bdnf) in patients experiencing a first episode of major depression (md) ( |
2022-05-23 |
2023-08-13 |
Not clear |
| Guoli Wang, Tianyue An, Cong Lei, Xiaofeng Zhu, Li Yang, Lianxue Zhang, Ronghua Zhan. Antidepressant-like effect of ginsenoside Rb1 on potentiating synaptic plasticity via the miR-134-mediated BDNF signaling pathway in a mouse model of chronic stress-induced depression. Journal of ginseng research. vol 46. issue 3. 2022-05-23. PMID:35600767. |
antidepressant-like effect of ginsenoside rb1 on potentiating synaptic plasticity via the mir-134-mediated bdnf signaling pathway in a mouse model of chronic stress-induced depression. |
2022-05-23 |
2023-08-13 |
mouse |
| Guoli Wang, Tianyue An, Cong Lei, Xiaofeng Zhu, Li Yang, Lianxue Zhang, Ronghua Zhan. Antidepressant-like effect of ginsenoside Rb1 on potentiating synaptic plasticity via the miR-134-mediated BDNF signaling pathway in a mouse model of chronic stress-induced depression. Journal of ginseng research. vol 46. issue 3. 2022-05-23. PMID:35600767. |
brain-derived neurotrophic factor (bdnf)-tropomyosin-related kinase b (trkb) plays a critical role in the pathogenesis of depression by modulating synaptic structural remodeling and functional transmission. |
2022-05-23 |
2023-08-13 |
mouse |
| Luke C Jenkins, Wei-Ju Chang, Valentina Buscemi, Matthew Liston, Peter Humburg, Michael Nicholas, Thomas Graven-Nielsen, Paul W Hodges, James H McAuley, Siobhan M Schabru. Cortical function and sensorimotor plasticity are prognostic factors associated with future low back pain after an acute episode: the UPWaRD prospective cohort study. Pain. 2022-05-13. PMID:35559930. |
when lbp outcome was dichotomised, sensory cortex and corticomotor excitability, bdnf genotype, depression and anxiety, lbp history and baseline pain intensity, discriminated between those who did and did not report lbp at six months (c-statistic 0.91). |
2022-05-13 |
2023-08-13 |
Not clear |
| Sagun Tiwari, Lili Qi, John Wong, Zhenxiang Ha. Association of peripheral manifestation of brain-derived neurotrophic factor with depression: A meta-analysis. Brain and behavior. 2022-05-05. PMID:35510613. |
the relationship between brain-derived neurotrophic factor (bdnf) and depression is a hot topic in research as several results of preclinical and clinical studies have shown controversial results. |
2022-05-05 |
2023-08-13 |
Not clear |
| Sagun Tiwari, Lili Qi, John Wong, Zhenxiang Ha. Association of peripheral manifestation of brain-derived neurotrophic factor with depression: A meta-analysis. Brain and behavior. 2022-05-05. PMID:35510613. |
our meta-analysis aims to evaluate and update the current status of peripheral bdnf with depression. |
2022-05-05 |
2023-08-13 |
Not clear |
| Assiya Kussainova, Laura Kassym, Almira Akhmetova, Eugenia Dvoryankova, Natalya Glushkova, Zaituna Khismetova, Saltanat Adilgozhina, Raikhan Tuleutayeva, Alida Kaskabayeva, Meruyert Massabayeva, Laura Pak, Yuliya Semenov. Associations between serum levels of brain-derived neurotrophic factor, corticotropin releasing hormone and mental distress in vitiligo patients. Scientific reports. vol 12. issue 1. 2022-05-04. PMID:35508633. |
the aim of our study was to investigate serum brain-derived neurotrophic factor (bdnf) and corticotropin releasing hormone (crh) levels in vitiligo patients and healthy controls in relation to the observed symptoms of depression and anxiety disorders. |
2022-05-04 |
2023-08-13 |
Not clear |
| Assiya Kussainova, Laura Kassym, Almira Akhmetova, Eugenia Dvoryankova, Natalya Glushkova, Zaituna Khismetova, Saltanat Adilgozhina, Raikhan Tuleutayeva, Alida Kaskabayeva, Meruyert Massabayeva, Laura Pak, Yuliya Semenov. Associations between serum levels of brain-derived neurotrophic factor, corticotropin releasing hormone and mental distress in vitiligo patients. Scientific reports. vol 12. issue 1. 2022-05-04. PMID:35508633. |
vitiligo is associated with the depression and is closely linked with lower bdnf levels. |
2022-05-04 |
2023-08-13 |
Not clear |
| Xinxin Liu, Zixin Hou, Mingming Han, Kemin Chen, Yuxia Wang, Jie Qing, Fengrui Yan. Salvianolic acid B alleviates comorbid pain in depression induced by chronic restraint stress through inhibiting GABAergic neuron excitation via an ERK-CREB-BDNF axis-dependent mechanism. Journal of psychiatric research. vol 151. 2022-05-02. PMID:35500448. |
overexpressed bdnf activated erk-creb-bdnf signaling pathway to alleviate comorbid pain in crs-induced depression. |
2022-05-02 |
2023-08-13 |
mouse |
| Marcos Brandão Contó, Ricardo Pautassi, Rosana Camarin. Rewarding and antidepressant properties of ketamine and ethanol: effects on the BDNF and TrkB and p75 Neuroscience. 2022-04-26. PMID:35469972. |
rewarding and antidepressant properties of ketamine and ethanol: effects on the bdnf and trkb and p75 there is a high level of comorbidity between depression and alcohol use disorder. |
2022-04-26 |
2023-08-13 |
mouse |
| Zofia Kotkowska, Dominik Strzeleck. Depression and Autoimmune Hypothyroidism-Their Relationship and the Effects of Treating Psychiatric and Thyroid Disorders on Changes in Clinical and Biochemical Parameters Including BDNF and Other Cytokines-A Systematic Review. Pharmaceuticals (Basel, Switzerland). vol 15. issue 4. 2022-04-23. PMID:35455388. |
depression and autoimmune hypothyroidism-their relationship and the effects of treating psychiatric and thyroid disorders on changes in clinical and biochemical parameters including bdnf and other cytokines-a systematic review. |
2022-04-23 |
2023-08-13 |
Not clear |
| Zofia Kotkowska, Dominik Strzeleck. Depression and Autoimmune Hypothyroidism-Their Relationship and the Effects of Treating Psychiatric and Thyroid Disorders on Changes in Clinical and Biochemical Parameters Including BDNF and Other Cytokines-A Systematic Review. Pharmaceuticals (Basel, Switzerland). vol 15. issue 4. 2022-04-23. PMID:35455388. |
depression is accompanied by the changes in the levels of inflammatory and trophic factors, including interleukins (il-1beta, il-2, il-6), interferon alpha (ifn-alpha), tumor necrosis factor alpha (tnf-alpha), c-reactive protein (crp), and brain derived neurotrophic factor (bdnf). |
2022-04-23 |
2023-08-13 |
Not clear |
| C Thirumoorthy, M Deepa, B N Srikumar, W Hannah, U Venkatesan, P J Nikhil, S Hemavathy, B Binukumar, R M Anjana, Uma Ram, M Balasubramanyam, P Saravanan, V Mohan, K Gokulakrishna. Altered levels of neurobiological biomarkers at the interface of depression and gestational diabetes mellitus in Asian Indian women. Neuropeptides. vol 93. 2022-04-23. PMID:35461022. |
the present study profiled the circulating levels of brain-derived neurotrophic factor (bdnf), beta endorphin (be) and nesfatin-1 in women with gdm (with and without depression). |
2022-04-23 |
2023-08-13 |
Not clear |
| Alexandra Schosser, Daniela Fischer-Hansal, Marleen M Swoboda, Birgit Ludwig, Laura Carlberg, Patrick Swoboda, Klemens Kienesberger, Alexandra Bernegger, Monika Fuxjäger, Melanie Zotter, Nicolas Schmelzle, Michelle Inaner, Romina Koller, Nestor D Kapusta, Helmuth Haslacher, Martin Aigner, Siegfried Kasper, Birgit Senf. BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression: to be submitted to: European Neuropsychopharmacology. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 58. 2022-04-22. PMID:35453068. |
bdnf gene polymorphisms predicting treatment response to cbt-based rehabilitation of depression: to be submitted to: european neuropsychopharmacology. |
2022-04-22 |
2023-08-13 |
Not clear |
| Alexandra Schosser, Daniela Fischer-Hansal, Marleen M Swoboda, Birgit Ludwig, Laura Carlberg, Patrick Swoboda, Klemens Kienesberger, Alexandra Bernegger, Monika Fuxjäger, Melanie Zotter, Nicolas Schmelzle, Michelle Inaner, Romina Koller, Nestor D Kapusta, Helmuth Haslacher, Martin Aigner, Siegfried Kasper, Birgit Senf. BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression: to be submitted to: European Neuropsychopharmacology. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 58. 2022-04-22. PMID:35453068. |
we conclude that bdnf might serve as promising genetic marker for treatment response to psychological treatment in depression. |
2022-04-22 |
2023-08-13 |
Not clear |
| Weronika Zwolińska, Maria Skibinska, Agnieszka Słopień, Monika Dmitrzak-Węglar. ProBDNF as an Indicator of Improvement among Women with Depressive Episodes. Metabolites. vol 12. issue 4. 2022-04-21. PMID:35448545. |
we also aimed to investigate the differences in bdnf, probdnf, and s100b levels between depression in the course of bipolar disorder (bd) and major depressive disorder (mdd). |
2022-04-21 |
2023-08-13 |
Not clear |
| Qian Wu, Wen-Zhen Duan, Jian-Bei Chen, Xiao-Peng Zhao, Xiao-Juan Li, Yue-Yun Liu, Qing-Yu Ma, Zhe Xue, Jia-Xu Che. Extracellular Vesicles: Emerging Roles in Developing Therapeutic Approach and Delivery Tool of Chinese Herbal Medicine for the Treatment of Depressive Disorder. Frontiers in pharmacology. vol 13. 2022-04-11. PMID:35401216. |
evs play a vital role in the pathogenesis of depression by transporting mirna and effector molecules such as bdnf, il34. |
2022-04-11 |
2023-08-13 |
Not clear |